Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia.
Saved in:
| Title: | Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia. |
|---|---|
| Authors: | Rodriguez V; Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., O'Brien SH; Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH., Orgel E; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA.; Keck School of Medicine, University of Southern California, Los Angeles, CA., Schultz CL; Nemours Center for Cancer and Blood Disorders, Nemours Children's Health, Wilmington, DE., Esbenshade AJ; Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN., Memaj A; Biostatistics Medical Affairs, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Dyme JL; Clinical Science Program, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Favatella NA; Clinical Science Program, Bristol Myers Squibb, Inc, Lawrenceville, NJ., Mitchell LG; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada. |
| Source: | Blood advances [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4738-4747. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
